AgeX director Michael H. May will not stand for re-election at December 2023 annual meeting

Serina Therapeutics, Inc.

Dr. May cited need to reduce external commitments; no disagreement with AgeX.
He serves on Audit, Compensation, and Nominating and Corporate Governance committees.
His departure is effective upon the annual meeting expected in December 2023.
No replacement named; board composition will change at that time.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Michael H. May

Director

SER · Serina Therapeutics, Inc.

Filed: September 8, 2023, 7:59 PM ET

On September 1, 2023, Dr. Michael H. May informed us that he does not intend to stand for re-election as a director at our next annual meeting of stockholders, which is expected to be held during December of this year.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael H. May departed as Director at Serina Therapeutics, Inc..

Action: does not intend to stand for re-election
Role: Director

Exact text from the filing

On September 1, 2023, Dr. Michael H. May informed us that he does not intend to stand for re-election as a director at our next annual meeting of stockholders, which is expected to be held during December of this year.

View on SEC.gov

Serina Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-032095

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.